Fabián P Alvarez (F P Alvarez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Journal of medical economics

Human vaccines & immunotherapeutics

Influenza and other respiratory viruses

PloS one

Sanofi Pasteur

Universidad de la República, Facultad de Ciencias (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi Pasteur

France

Health Economist

Education History

Universidad de la República, Facultad de Ciencias

Uruguay

PHD

Publications

Fabián P Alvarez, L Allard, F Bianic, Hélène Bricout, Pascal Crépey, J Gaillat, Gaëtan Gavazzi, A Mosnier, Odile Launay, M C Levant, D Proshenska, Caroline de Courville
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population. Journal of medical economics (2024)
Fabián P Alvarez, Pierre Chevalier, Matthias Borms, Hélène Bricout, Catia Marques, Anu Soininen, Tatu Sainio, Christine Petit, Caroline de Courville
Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal. Journal of medical economics (2023)
Caroline de Courville, Sarah M Cadarette, Erika Wissinger, Fabián P Alvarez
The economic burden of influenza among adults aged 18 to 64: A systematic literature review. Influenza and other respiratory viruses 16 (3) (2022)
Richard Mattock, Ilana Gibbons, Joe W E Moss, Stuart Mealing, Nathalie Largeron, Stuart Carroll, Fabián P Alvarez
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales. Journal of medical economics 24 (1) (2021)
Fabián P Alvarez, Audrey Petitjean, Joshua Nealon, Rosalind Hollingsworth, Juan Luis López-Belmonte
Cost-effectiveness analysis has to consider all available evidence when informing inputs. Human vaccines & immunotherapeutics 17 (3) (2020)
Pascal Crépey, Esther Redondo, Javier Díez-Domingo, Raul Ortiz de Lejarazu-Leonardo, Federico Martinón-Torres, Ángel Gil de Miguel, Juan Luis López-Belmonte, Fabián P Alvarez, Hélène Bricout, Míriam Solozabal
From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. PloS one 15 (5) (2020)
Guillermo M Ruiz-Palacios, John H Beigel, Maria Lourdes Guerrero, Lucile Bellier, Ramiro Tamayo, Patricia Cervantes, Fabián P Alvarez, Arturo Galindo-Fraga, Felipe Aguilar-Ituarte, Juan Guillermo Lopez
Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico. Human vaccines & immunotherapeutics 16 (4) (2019)

Fabián P Alvarez.css-eqlu8i{font-size:small;padding-left:4px;} (F P Alvarez)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabián P Alvarez (F P Alvarez)